Eximis Surgical
Pre-clinicalLeave nothing harmful behind. Eximis Surgical Corporation announces a breakthrough process for performing Truely Minimally Invasive Speciman Removal in Laparoscopic Surgery.
Founded
2018
Focus
Medical DevicesSurgery
About
Leave nothing harmful behind. Eximis Surgical Corporation announces a breakthrough process for performing Truely Minimally Invasive Speciman Removal in Laparoscopic Surgery.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationAustin, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile